Organization
Washington State University
10 clinical trials
Clinical trial
Evaluating a Potential Pharmacokinetic Kratom-oxycodone Interaction Concurrent With Clinical EndpointsStatus: Recruiting, Estimated PCD: 2025-05-01
Clinical trial
A Phase II Randomized, Double-blind, Placebo-controlled Clinical Trial (RCT) to Evaluate the Ability of Mirtazapine (MZP) to Increase Methamphetamine (MA) Abstinence Among Treatment-seeking Medication for Opioid Use Disorder (MOUD) AdultsStatus: Not yet recruiting, Estimated PCD: 2026-04-01
Clinical trial
Evaluating the Pharmacokinetics and Drug Interaction Potential of the Botanical Dietary Supplement CinnamonStatus: Active (not recruiting), Estimated PCD: 2023-08-31
Clinical trial
Assessing the Pharmacokinetics and Drug Interaction Liability of Kratom, an Opioid-like Natural ProductStatus: Completed, Estimated PCD: 2021-08-31
Clinical trial
Pharmacokinetic Drug-Drug Interaction Study to Identify Biomarkers of Kidney TransportersStatus: Completed, Estimated PCD: 2023-07-22
Clinical trial
Acute Effects of Cannabis on Everyday Life MemoryStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Pilot Study to Assess the Contribution of UGT2B17 and Associated Genetic Polymorphisms on the Pharmacokinetics of Diclofenac Alone and Upon Co-administration With CurcuminStatus: Recruiting, Estimated PCD: 2024-08-18
Clinical trial
Assessing Goldenseal-drug Interactions Using a Probe Drug Cocktail ApproachStatus: Completed, Estimated PCD: 2018-11-30
Clinical trial
Clinical Evaluation of the Pharmacokinetic Goldenseal-Metformin Interaction in Diabetic PatientsStatus: Active (not recruiting), Estimated PCD: 2023-01-16
Clinical trial
Zonisamide for the Treatment of Alcohol Use Disorder in the Addiction Neuroclinical Assessment FrameworkStatus: Recruiting, Estimated PCD: 2025-08-01